期刊文献+

海洋细菌抗肿瘤活性菌株的筛选与鉴定 被引量:8

The screening and identification of marine bacteria with antitumor activity
在线阅读 下载PDF
导出
摘要 采用MTT法对分离自美国圣璜岛海域的251株海洋细菌进行抗肿瘤活性的筛选,以期从海洋环境中筛选出具有抗肿瘤活性的菌株,为新型抗肿瘤药物开发提供新的天然产物资源。结果表明:54株海洋菌有较好的抗肿瘤活性,在测试浓度为100μg·mL-1时,对HeLa细胞的抑制率均大于50%,占总测试菌株的21.5%,其中有7株菌株对HeLa细胞的抑制率在85%以上。在所有活性菌株中,菌株No.657的活性最强,其液体发酵及固体发酵的提取物,对HeLa细胞的IC50分别为36.53、3.19μg·mL-1,经菌株形态的观察和16SrDNA序列分析鉴定,该菌株为变形斑沙雷氏菌Serratia proteamaculans。这表明,海洋微生物是抗肿瘤活性物质的重要来源,菌株No.657是一株很好的抗肿瘤活性菌,其固体发酵更适宜其活性代谢产物的产生。 The antitumor activity of some marine bacterial isolates was investigated to provide potential active strains as well as novel active compounds for the antitumor drug development.In this study,by using MTT assay,we screened for the antitumor activity from some marine bacterial strains which were isolated from San Juan Island.The results showed that,among 251 tested bacterial isolates,54 isolates(about 21.5%) showed better antitumor activity.Their inhibition rates against HeLa cell at the concentration of 100 μg·mL-1 were higher than 50%.And 7 of them showed stronger antitumor activity with the inhibitory rate higher than 85%.Among all the active strains,bacterium No.657 showed the most remarkable antitumor activities.The antitumor activities(IC50) of its metabolies extracted from liquid fermentation and solid-state fermentation were 36.53 and 3.19 μg·mL-1,respectively.This strains was identified as Serratia proteamaculans,according to its morphological observation and 16S rDNA sequence analysis.Our results indicated that marine microorganisms are an important source of antitumor substances.Isolate No.657 might be a good antitumor active strain and the solid-state fermentation should be better for its active metabolites production.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2012年第2期18-22,共5页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 国家自然科学基金资助项目(41076097 41006097 41106113) 新药研究国家重点实验室开放基金项目(SIMM1106KF-09)
关键词 海洋细菌 抗肿瘤活性 MTT法 抑制率 marine bacteria antitumor activities MTT assay the inhibition rate
  • 相关文献

参考文献23

  • 1齐相薇,张湘宁,黄培春.抗肿瘤海洋生物活性物质的研究进展[J].海南医学,2012,23(2):118-121. 被引量:4
  • 2姜健,杨宝灵,鲁红凯,元起,桂佳,关圩秀.海洋微生物生物活性物质的研究[J].云南大学学报(自然科学版),2004,26(S2):91-95. 被引量:9
  • 3Schumacher M, Kelkel M, Dicato M, et al. A survey o{ marine natural compounds and their derivatives with anti- cancer activity reported in 2010 [J]. Molecules, 2011, 16(7) : 5629-5646.
  • 4Hickford S J H, Blunt J W, Munro M H G. Antitumour polyether maerolides: four new haliehondrins from the New Zealand deep-water marine sponge Lissodendorya: sp [J]. Bioorganie and Medicinal Chemistry, 2009, 17(6): 2199-2203.
  • 5Aoki S, Cao L, Matsui K, et al. Kendarimide A, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp [J]. Tetrahedron, 2004, 60(33): 7053-7059.
  • 6Rodriguez A, Martinez N. Marine antitumor agents: 14-deoxycrassin and pseudoplexaurol, new cembranoid direr- penes from the caribbean gorgonian Pseudoplexaura porosa [J]. Cellular and Molecular Life Sciences, 1993, 49(2) : 179-181.
  • 7Hassan H M, Khanfar M A, Elnagar A Y, et al. Pachycladins A-E, prostate cancer invasion and migration inhibi- tory eunicellin-based diterpenoids from the red sea soft coral cladiella pachyclados [J]. Journal of Natural Products, 2010, 73(5): 848-853.
  • 8Gradishar W J. The place for eribulin in the treatment of metastatic breast cancer [J]. Current Oncology Reports, 2011, 13(1): 1-6.
  • 9D'Incalci M, Galmarini C M. A review of trabectedin (ET-743): a unique mechanism of action [J]. Molecular Cancer Therapeutics, 2010, 9(8): 2157-2163.
  • 10Medina R A, Goeger D E, Hills P, et al. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Pan- amanian marine cyanobacterium Leptolyngbya sp [J]. Journal of the American Chemical Society, 2008, 130(20) : 6324-6325.

二级参考文献52

  • 1方金瑞,黄维真.日本从海洋微生物开发新型生物活性物质研究的新进展[J].中国海洋药物,1995,14(4):21-25. 被引量:17
  • 2[3]John F D. Marine natural products [J]. Natural Product Reports, 1998,15:113
  • 3[4]John F D. Marine natural products [J]. Natural Product Reports, 2000,17:7
  • 4[5]Kobayashi J, Ishibashi M. Bioactive metabolites of symbiotic marine microorganisms [J]. Chem Rev, 1993,93:1753
  • 5[6]Shigemori H M A, Bae K, Yazawa T, et al. Alteramide A: a new tetracyclic alkaloid from a bacterium Alteromonas sp. Associated with the marine sponge Halichondria [J]. J Org Chem,1992,57:4317
  • 6[7]Unson M D, Holland N D, Faulkner D J. A brominated secondary metabolite synthesized by the cyanobacterial symbiont of a marine sponge and accumulation of the crystalline metabolite in the sponge tissue [J]. Mar Biol,1994,199:1
  • 7[8]Staley J T, Bryant M P, Pfenning N, et al. Bergy's manual of systematic bacteriology [M]. Baltimore: Williams and Wilkins,1984~1989,Vol. Ⅱ
  • 8Rinehart KL. Antitumor compounds from tunicates [J]. Med Res Rev, 2000, 20(1): 1-27.
  • 9O'Hanlon LH. Scientists are searching the seas for cancer drugs [J]. J Natl Cancer Inst, 2005, 98(10): 662-663.
  • 10Mitsiades CS, Ocio EM, Pandiella A, et al. Aplidin, a marine organ- ism derived compound with potent antimyeloma activity in vitro and in vivo [J]. Cancer Res, 2008, 68(13): 5216-5225.

共引文献139

同被引文献99

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部